These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 32449143

  • 21. The Effect of Hispidulin, a Flavonoid from Salvia plebeia, on Human Nasopharyngeal Carcinoma CNE-2Z Cell Proliferation, Migration, Invasion, and Apoptosis.
    Dai Y, Sun X, Li B, Ma H, Wu P, Zhang Y, Zhu M, Li HM, Qin M, Wu CZ.
    Molecules; 2021 Mar 14; 26(6):. PubMed ID: 33799348
    [Abstract] [Full Text] [Related]

  • 22. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 14; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Expression and functional implications of YME1L in nasopharyngeal carcinoma.
    Cheng F, Huang H, Yin S, Liu JS, Sun P.
    Cell Death Dis; 2024 Jun 18; 15(6):423. PubMed ID: 38890304
    [Abstract] [Full Text] [Related]

  • 25. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z, Ruinian Z, Liji J, Chun Z, Qiaolan Z, Jun J, Yuming C, Junrong H.
    Technol Cancer Res Treat; 2020 Jun 18; 19():1533033819892251. PubMed ID: 31984860
    [Abstract] [Full Text] [Related]

  • 26. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X, Zhou R, Li Q, Jie X, Hong J, Zong Y, Dong X, Zhang S, Li Z, Wu G.
    Anticancer Drugs; 2019 Mar 18; 30(3):241-250. PubMed ID: 30640793
    [Abstract] [Full Text] [Related]

  • 27. miR-141-3p promotes proliferation and metastasis of nasopharyngeal carcinoma by targeting NME1.
    Li M, Huang H, Cheng F, Hu X, Liu J.
    Adv Med Sci; 2020 Sep 18; 65(2):252-258. PubMed ID: 32299022
    [Abstract] [Full Text] [Related]

  • 28. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z, Li W, Ai J, Xie J, Zhang X.
    J Transl Med; 2022 Jun 08; 20(1):264. PubMed ID: 35676661
    [Abstract] [Full Text] [Related]

  • 29. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma.
    Zhang J, Jiang Y, Yu Y, Li J.
    Eur J Pharmacol; 2022 Jan 15; 915():174688. PubMed ID: 34883074
    [Abstract] [Full Text] [Related]

  • 30. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
    Xie M, Yi X, Wang R, Wang L, He G, Zhu M, Qi C, Liu Y, Ye Y, Tan S, Tang A.
    Cell Physiol Biochem; 2014 Jan 15; 33(5):1475-83. PubMed ID: 24854624
    [Abstract] [Full Text] [Related]

  • 31. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
    Wang J, Shang Y, Wang Y, Li Y, Wang L, Huang S, Lyu X.
    Histol Histopathol; 2024 May 15; 39(5):647-657. PubMed ID: 37971211
    [Abstract] [Full Text] [Related]

  • 32. TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR signalling pathway.
    Liu Y, Qi X, Zhao Z, Song D, Wang L, Zhai Q, Zhang X, Zhao P, Xiang X.
    J Cell Mol Med; 2020 Aug 15; 24(16):9135-9144. PubMed ID: 32588529
    [Abstract] [Full Text] [Related]

  • 33. Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo.
    Chen JC, Hsieh MJ, Chen CJ, Lin JT, Lo YS, Chuang YC, Chien SY, Chen MK.
    Oncotarget; 2016 Oct 25; 7(43):70276-70289. PubMed ID: 27602962
    [Abstract] [Full Text] [Related]

  • 34. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F, Pan Q, Wang L, Yi S, Liu P, Huang W.
    Biofactors; 2020 Jul 25; 46(4):675-684. PubMed ID: 32449282
    [Abstract] [Full Text] [Related]

  • 35. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
    Wang MH, Sun R, Zhou XM, Zhang MY, Lu JB, Yang Y, Zeng LS, Yang XZ, Shi L, Xiao RW, Wang HY, Mai SJ.
    Cell Death Dis; 2018 Jan 05; 9(1):2. PubMed ID: 29305578
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma.
    Wu LZ, Huang ML, Qi CL, Shen LJ, Zou Y, Yang R, Sheng JF, Chen SM.
    Bioengineered; 2021 Dec 05; 12(1):3398-3409. PubMed ID: 34224316
    [Abstract] [Full Text] [Related]

  • 37. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
    Zhang M, Zhou X, Zhou K.
    Int J Mol Med; 2013 Mar 05; 31(3):621-7. PubMed ID: 23314035
    [Abstract] [Full Text] [Related]

  • 38. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.
    Cao LH, Li HT, Lin WQ, Tan HY, Xie L, Zhong ZJ, Zhou JH.
    Sci Rep; 2016 Jan 05; 6():18706. PubMed ID: 26729257
    [Abstract] [Full Text] [Related]

  • 39. Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway.
    Lin YT, Wang HC, Hsu YC, Cho CL, Yang MY, Chien CY.
    Int J Mol Sci; 2017 Jun 23; 18(7):. PubMed ID: 28644386
    [Abstract] [Full Text] [Related]

  • 40. Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma.
    Wong CH, Loong HH, Hui CW, Lau CP, Hui EP, Ma BB, Chan AT.
    Invest New Drugs; 2013 Dec 23; 31(6):1399-408. PubMed ID: 23975511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.